Abstract
Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when boron-10 is irradiated with thermal neutrons to yield stripped down helium nuclei (alpha particles) and recoiling lithium-7 nuclei.1
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G. L. Locher, Biological effects of therapeutic possibilities of neutrons. Amer. J. Roentgenol. 36: 1 (1936).
R. F. Barth, F. Alam, A. H. Soloway, D. M. Adams, and Z. Steplewski, Boronated monoclonal antibody 17–1A for potential neutron capture therapy of colorectal cancer. Hybridoma 5: Suppl. 1: S43 (1986).
A. H. Soloway, H. Hatanaka, and M. A. Davis, Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J. Med. Chem. 10: 714 (1967).
Y. Mishima and T. Shimakage, Thermal neutron capture treatment of malignant melanomas using 10B-Dopa and nB12 chlorpromazine compounds. Pigment Cell 2: 394 (1976).
R. G. Fairchild, D. Greenberg, K. P. Watts, S. Packer, H. L. Atkins, P. Som, S. J. Hannon, A. B. Brill, I. Fand, and W. P. McNally, Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma. Cancer Res. 42: 556 (1982).
A. H. Soloway, F. Alam, R. F. Barth, N. Mafune, B. Bapat and D. M. Adams, The development of boron compounds for use in neutron capture therapy. Proc. Imboron VI Meeting June 22–26, 1987, Rez, Czechoslovakia (1988, In Press).
M. Herlyn, Z. Steplewski, D. Herlyn and H. Koprowksi, CO 17–1A and related monoclonal antibodies: their production and characterization. Hybridoma 5: Suppl. 1: S3 (1986).
C. W. Johnson, R. F. Barth, D. Adams, B. Holman, J. E. Price and I. Sautins, Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies. Cancer Res. 47: 1111 (1987).
F. Alam, A. H. Soloway, R. F. Barth and D. M. Adams, Chemoradiotherapy of cancer: boronated antibodies and boron containing derivatives of promazine for neutron capture therapy. in “Neutron Capture Therapy.” Proc. Second Int’l Sympos. on Neutron Capture Therapy pp 8–16. H. Hatanaka, ed. Nishimura, Niigata, Japan (1986).
N. Kobayashi, N. Allen, N. R. Clendenon and L. Ko, An improved rat brain tumor model. J. Neurosurg. 53: 808 (1980).
T. E. Blue, T. C. Roberts, R. F. Barth, J. W. Talnagi and F. Alam, Boron-10 concentration measurements using the solid-state nuclear track detector CR-39 and automatic image analysis. Nuclear Technology 77: 220 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Barth, R.F. et al. (1989). Pre-Clinical Studies on Boron Neutron Capture Therapy. In: Fairchild, R.G., Bond, V.P., Woodhead, A.D., Vivirito, K. (eds) Clinical Aspects of Neutron Capture Therapy. Basic Life Sciences, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5622-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5622-6_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5624-0
Online ISBN: 978-1-4684-5622-6
eBook Packages: Springer Book Archive